Scilex Holding Co
SCLXNasdaqCIK 1820190HealthcareFiscal year ends Dec 31
Reports and events: 215 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-2217:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-171344 |
| 2023-06-2021:52 ET | S-1/A | Registration statement, amended | 0001193125-23-169259 |
| 2023-06-0506:07 ET | S-1/A | Registration statement, amended | 0001193125-23-160231 |
| 2023-06-0109:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-158495 |
| 2023-05-2321:06 ET | S-1/A | Registration statement, amended | 0001193125-23-150788 |
| 2023-05-1216:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021743 |
| 2023-05-0516:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-137199 |
| 2023-05-0312:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-133984 |
| 2023-04-2621:53 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-116108 |
| 2023-04-2117:20 ET | S-1 | Registration statement | 0001193125-23-110713 |
| 2023-04-2016:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-108354 |
| 2023-04-1116:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-097796 |
| 2023-04-1017:15 ET | S-1 | Registration statement | 0001193125-23-096647 |
| 2023-04-0309:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-089024 |
| 2023-03-2116:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-075731 |
| 2023-03-0816:17 ET | DEF 14A | Proxy statementPeriod 2023-04-06 | 0001193125-23-064537 |
| 2023-03-0717:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-006493 |
| 2023-03-0309:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-059136 |
| 2023-03-0106:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-055030 |
| 2023-02-1316:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-035934 |
| 2023-02-0916:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-030002 |
| 2023-02-0606:05 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-024777 |
| 2023-02-0216:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-022773 |
| 2023-02-0209:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-022210 |
| 2023-01-3006:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-018205 |
| 2023-01-2316:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-013193 |
| 2023-01-1713:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-009256 |
| 2023-01-1216:45 ET | S-1 | Registration statement | 0001193125-23-007234 |
| 2023-01-0906:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-004041 |
| 2023-01-0309:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-000315 |
| 2022-12-2019:47 ET | S-1/A | Registration statement, amended | 0001193125-22-308547 |
| 2022-11-3016:09 ET | S-1 | Registration statement | 0001193125-22-295391 |
| 2022-11-3016:05 ET | S-1 | Registration statement | 0001193125-22-295370 |
| 2022-11-1820:34 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-22-287974 |
| 2022-11-1717:09 ET | SC 13D | Ownership report, active investor | 0001193125-22-287802 |
| 2022-11-1717:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-287783 |
| 2022-11-0917:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-116569 |
| 2022-11-0416:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-069366 |
| 2022-10-3107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-112677 |
| 2022-10-1816:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-109728 |
| 2022-09-1420:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-22-099785 |
| 2022-08-1216:10 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-047404 |
| 2022-07-0509:21 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-036989 |
| 2022-06-0708:44 ET | DEF 14A | Proxy statementPeriod 2022-06-30 | 0001213900-22-031478 |
| 2022-05-2316:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-028923 |
| 2022-05-1616:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-027064 |
| 2022-04-1117:00 ET | 8-K/A | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-019222 |
| 2022-04-1108:01 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-019090 |
| 2022-03-2121:40 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-013697 |
| 2022-02-2416:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-009229 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.